Mirum Pharmaceuticals (MIRM) Inventory (2021 - 2026)

Mirum Pharmaceuticals' Inventory history runs 6 years deep, the most recent figure standing at $25.5 million for Q1 2026.

• In Q1 2026, Inventory rose 13.83% year-over-year to $25.5 million; the TTM figure through Mar 2026 stood at $25.5 million (up 13.83% YoY), while the FY2025 annual figure was $24.9 million, up 11.09% from the prior year.
• Inventory for Q1 2026 stood at $25.5 million, up from $24.9 million in the prior quarter.
• The five-year high for Inventory was $25.5 million in Q1 2026, with the low at $1.6 million in Q1 2022.
• The 5-year median for Inventory is $21.6 million (2024), against an average of $16.7 million.
• The sharpest annual moves came in 2023 and 2024: Inventory surged 318.54% in 2023, then dropped 2.95% in 2024.
• Mirum Pharmaceuticals' Inventory stood at $5.6 million in 2022, then surged by 300.93% to $22.3 million in 2023, then increased by 0.41% to $22.4 million in 2024, then climbed by 11.09% to $24.9 million in 2025, then grew by 2.54% to $25.5 million in 2026.
• Business Quant data shows MIRM's Inventory at $25.5 million in Q1 2026, $24.9 million in Q4 2025, and $24.0 million in Q3 2025.